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BrazilIV-1 harbors the V3 tip GWGR instead of the GPGR. To investigate the evolution
of GW variants, we analyzed 81 env sequences and 5 full-length GW genomes from antiretroviral-naïve
individuals sampled between 1983 and 1999. Phylogenetic analysis indicated that GW strains intermingle in
the tree with other subtype B sequences. The mean dN/dS values of GW strains were proximal to those of the
other sequences, regardless of sampling years or clinical status. In sequences from patients with CD4+ T cell
counts ≥200 cells/μL, the mean dN/dS ratio was greater than one, suggesting a positive selection. The
prevalence of GW variants was lower among individuals in whom disease progressed. This is probably
attributable to the fact that tryptophan is replaced by other amino acids over time, whereas the GP motif
does not evolve as rapidly.
© 2008 Elsevier Inc. All rights reserved.Introduction
The potential of HIV-1 to generate genetic diversity is remarkable.
This diversity results from the elevated rate at which the viral reverse
transcriptase incorporates errors during the numerous replication
events occurring in infected patients (Ho et al., 1995; Roberts,
Bebenek, and Kunkel, 1988; Wei et al., 1995). At the global level,
HIV-1 strains are classiﬁed as belonging to one of three groups (M, N
or O), nine subtypes (A, B, C, D, F, G, H, J or K) and 34 circulating
recombinant forms (http://www.hiv.lanl.gov/content/hiv-db/CRFs/
CRFs.html). In Brazil, HIV-1 subtypes B, F and C, as well as unique
and circulating recombinant forms, are co-circulating (Bongertz et al.,
2000; Csillag, 1994; De Sa Filho et al., 2006; Louwagie et al., 1994;
Morgado et al., 1998; Morgado et al., 1994; Potts et al., 1993; Ramos et
al., 1999; Sa Filho et al., 2005; Santos et al., 2006; Thomson et al.,
2004). In 1993 (Potts et al., 1993), it became apparent that Brazilian
subtype B strains contained an antigenically distinct variant that has a
signature motif at the tip of the V3 loop, with tryptophan rather than
proline at position 328 in the HIV-1 envelope (Casseb et al., 1998; da
Costa et al., 1995; Potts et al., 1993). It has consistently been shown
that this variant accounts for approximately half of the subtype B
strains circulating in Brazil and is exceedingly rare in other parts of thePedro de Toledo 781, 16 andar,
55 11 41923176.
l rights reserved.world (Bongertz et al., 2000; Casseb et al., 1998; Morgado et al., 1994).
Analysis of Brazilian GWGR C2-V3-C3 and gp120 env sequences
indicated they are closely related to North American and European
subtype B strains, presenting 89.1% nucleic acid similarity to the North
American MN strain (da Costa et al., 1995), although a tryptophan-to-
proline substitution at this position requires a three-nucleotide
substitution. Interestingly, in two separate studies, conducted in
2000 and 2002, respectively, it was suggested that GWGR strains
possess particular biological properties, causing the pace of disease
progression to be slower in individuals infected with GWGR strains
than in those infected with the more common Brazilian GPGR strains
(Casseb et al., 2002; Santoro-Lopes et al., 2000).
In order to further investigate GWGR strains in Brazil, we
analyzed sequences of HIV subtype B presenting various motifs at
the tip of the V3 loop. The data related to these different sequences
were divided into four sets, by the group to which they relate: BR-
83 (the earliest available sequences in the Brazilian HIV epidemic,
15 sequences obtained in 1983); BR-94 (25 sequences obtained
from asymptomatic patients sampled in 1994); BR-95 (26
sequences obtained from symptomatic patients sampled in 1995);
and BR-99 (15 sequences obtained from untreated asymptomatic
patients collected in 1999). All samples were obtained from
antiretroviral-naïve individuals and therefore represent the natural
viral evolution of HIV in relation to the progression of the disease.
In addition, ﬁve full-length genomes from recently infected
individuals harboring the GWGR motif at the tip of the V3 loop
Table 1
Proportions of V3 variants by CD4+ T cell count
CD4+ T cell
cells/μL
Amino acid at the V3 tip tetramer
Proline Tryptophan Other Total
b200 17 (52%) 8 (24%) 8 (24%) 33
≥200 11 (33%) 18 (54%) 4 (12%) 33
Total 28 (43%) 26 (39%) 12 (18%)
185R.S. Diaz et al. / Virology 381 (2008) 184–193were compared to other, previously described, full-length genomes
of clade B strains.
Results
TheHIV-1 prevalence in theMSMpopulation evaluated in 1983was
36% (24 of the 66 patients tested). Using the dual EIA testing strategy,
we found that 44% of the individuals in the 1983 sample presented
recent HIV-1 infection (3A11-positive/3A11-DT-negative). The annual
incidence in this population was 59.8%. With the exception of the 5
HIV-1 negative controls, all of the samples were 3A11-positive. The
ODs were equivalent in all 6 duplicate pairs of samples. None of the 4
follow-up samples collected in 1986 were 3A11-DT-negative. Sample
BZ-328 (collected in 1983) was 3A11-DT-negative, and the follow-up
sample collected in 1986 from the same patient (sample BZ-380) was
3A11-DT-positive, showing the progressive increase in antibody titers
over time in this patient.
Wewere able to amplify and sequenceHIV from the sera of 15 of the
24 1993 samples. Of the 24 serum samples collected in 1983, 12 (50%)
presentedGW-speciﬁc peptide binding,10 (42%) presentedGP-speciﬁc
peptide binding, and 8% presented an indeterminate status. It is of note
that, in one sample presenting GPGR in the sequence analysis, GWGR
peptide-binding antibodies were identiﬁed. With this one exception,
therewas congruity between the sequences obtained and the peptide-
binding speciﬁcity. Sequenceswere also obtained from the 3 follow-up
samples, thereby conﬁrming the relationship between sequences
obtained in 1983 and 1985 (data not shown). Two sequences in which
the rare tetramers GAGR and GVGRwere detected were later classiﬁed
as GWGR in the GP-speciﬁc peptide-binding assay and, in the STARHS,
were not categorized as representing recent infections. Excluding
those 2 samples, the sequencing results showed that 6 individuals
harbored the GPGmotif and 7 harbored the GWGmotif. Interestingly, 8
samples collected in 1994 or 1995 and harboring other amino acids at
the P/W position, such as A (gcg), V (gtg), E (gag), F (ttt), and L (ttg), all
reacted asW in the peptide-binding assay. As can be seen inTable 1, the
prevalences of P and W vary according to the individual CD4+ T cell
counts, the prevalence of W being higher among individuals with less
evidence of progression (CD4 counts N200 cells/μL; chi-square
pb0.03). However, if we considered that amino acids other than P or
W are evolving from W, there would be no statistical differences
between the two groups (see further explanation bellow).
In order to investigate the possible evolutionary relationships
among GWGR samples, a V3 env maximum likelihood tree was
constructed using all of the sequences in the four data sets (BR-83, BR-
94, BR-95 and BR-99). In this tree (data not shown), GWGR sequences
tended to cluster, sequences with other V3 motifs grouping far from
the GWGR sequences. Since the fragments generated had only 216 bp,Fig. 1. HIV-1 C2-C3 env maximum likelihood tree constructed from a 204-bp fragment.
The Brazilian sequences are represented by circles, whereas HIV-1 group M reference
sequences are represented by diamonds. The blue circles represent samples obtained
from asymptomatic patients, red circles represent samples obtained from symptomatic
patients with CD4 counts b200 cells/μL, and magenta circles represent samples
obtained from symptomatic patients with CD4 counts ≥200 cells/μL. The V3 motifs of
the samples are represented to the right of the tree (only motifs other than GPGR are
shown). (For interpretation of the references to colour in this ﬁgure legend, the reader is
referred to the web version of this article.)
Fig. 2. HIV-1 gp120 env maximum likelihood tree constructed from a 746-bp fragment.
The Brazilian isolates are represented by blue circles, whereas HIV-1 subtype B
reference isolates are represented by dark diamonds, and other group M references are
represented by open diamonds. V3 motifs are represented to the right of tree (only
motifs other than GPGR are shown). (For interpretation of the references to colour in
this ﬁgure legend, the reader is referred to the web version of this article.)
186 R.S. Diaz et al. / Virology 381 (2008) 184–193it was unclear whether the grouping tendency of GWGR samples was
inﬂuenced by the 12-bp V3 tip motif. Therefore, a second maximum
likelihood tree was constructed using the same sequences without the
V3 tip tetramer. In this second tree (Fig. 1), sequences bearing GWGR,
GPGR or other V3 motifs did not establish clusters; rather, they were
all evenly dispersed throughout the tree. Therefore, other than the V3
tip signature, there were no mutations supporting the clustering of
GWGR samples in this fragment. In addition, we did not observe any
grouping in Brazilian subtype B V3 sequences, regardless of whether
they were sampled earlier (1983) or later (1999) in the epidemic or
whether they derived from symptomatic or asymptomatic patients.
However, in this second tree, the branches related to samples
collected in 1995 from symptomatic patients with CD4 counts N200
cells/μL (Fig. 1) were longer than those related to other samples within
the same phylogenetic pair.
Owing to the limited (216-bp) env fragment of the previous tree,
we decided to perform further analysis using a 746-bp env fragment
from Brazilian samples obtained in 1999, by this time maintaining the
V3 tip motif. Although the sequences with distinct motifs were
included in this analysis, they did not form a cluster sharing the same
V3 loop tetramer. Speciﬁcally, GWGR variants were evenly dispersed
throughout this tree. Nevertheless, Brazilian sequences had a
tendency to group together, away from the subtype B reference
strains obtained from other regions of the world (Fig. 2).
To further characterize the relationship between the GW variants
and other HIV-1 subtype B strains, we analyzed the full-length
genomes of six variants generated in this study in an attempt to
identify any GW related genetic signatures. Five of those sequences
presented GWGR at the V3 tip. For comparative purposes, we also
included in this analysis 50 full-length sequences of subtype B isolates
from other countries (obtained from the Los Alamos HIV database).
Those sequences included one full-length genome of a GW virus
previously isolated in Brazil (02BR008 GenBank ID: DQ358805) and
one of a GW virus previously isolated in Argentina (04AR143170
GenBank ID: DQ383750). In the tree, the sequences isolated in Brazil
(with the exception of sequence B.BR.89.BZ167, isolated in 1989) were
included in a well-deﬁned cluster with high a posteriori probability
(Fig. 3). This cluster included sequences from Brazil, Argentina and
Uruguay, suggesting that there is signiﬁcant cross-infection among
these countries. Notably, despite the fact that all isolates presenting
the GWGR tetramer, as well as the majority of all Brazilian isolates, are
monophyletic, they did not form a unique cluster. This suggests that
the current HIV-1 subtype B variants in Brazil originated from the
same ancestral sequence.
In order to perform a more in-depth analysis of Brazilian V3 env
sequences containing different signatures, we calculated mean
pairwise distances. To that end, we separated sequence data into
data sets by sampling year (BR-83, BR-94, BR-95 and BR-99, as
previouslymentioned), by V3 tetramer signature (BR-GPGR, BR-GWGR
and others) and by patient clinical status (symptomatic and asympto-
matic).Meanpairwise distances related to the V3 loop tetramer ranged
from 0.14 to 0.24. Similarly, mean pairwise distances related to the
sampling year ranged from 0.13 to 0.20, sequences isolated in 1983
(BR-83) presenting the least intragroup distance and those isolated in
1995 (BR-95) presenting the greatest (Table 2). Mean pairwise
distances related to patient clinical status ranged from 0.16 to 0.21,
data sets from symptomatic individuals presenting the highest values.
Data related to symptomatic patients were then further divided into
two data subsets: Sympt-SP, including sequences from patients with
CD4 counts ≤200 cells/μL; and Sympt-AP, including sequences from
patients with CD4 counts of 200 to 300 cells/μL. Interestingly, even
within this symptomatic category, we noticed that the mean pairwise
distance was greater in the data subset Sympt-AP (Table 2). Although
the previous analyses revealed subtle differences among the data sets,
these results should be evaluated with caution, since the pairwise
method is highly sensitive to the number and length of sequences.In addition, pairwise estimates of dN/dS ratios were also performed
in order to determine the selective regimes of the V3 loop variants.
Accordingly, dN/dS ratios (ω values) were not signiﬁcantly different
than 1 for all data, and we therefore could not reject the hypothesis of
neutral evolution (Table 2). Despite the lack of statistical support
(probably due to the small sample size and the shortness of the
187R.S. Diaz et al. / Virology 381 (2008) 184–193fragments analyzed), the observed inﬂation of the ω value in sympto-
matic individuals with high CD4 counts merited further study. There-
fore, we also analyzed the symptomatic individuals according to their
CD4 counts using a codon-based maximum likelihood method. The
results of this analysis are summarized in Table 3; the likelihood ratio
test indicated striking differences regarding the selective regime.
Speciﬁcally, in patients with CD4 countsb200 cells/μL, the number of
conserved sites (ω=0) was similar to that of neutral sites (ω=1)
according to the neutral model (model 1). However, according to the
discretemodel (model 3), inpatientswith CD4 counts≥200 cells/μL, 23%
of the sites were conserved, 40% were under purifying selection
(ω=0.35099), and 37% were under positive selection (ω=1.61380). In
addition, model 3 identiﬁed eight codons (33, 36, 45, 59, 62, 64, 65 and
67) as having the highest a posteriori probability (0.99) of positive
selection in the 216-bp C2-V3-C3 fragment (Table 3 and Fig. 4). Most of
these codons were located either in the vicinity of or within the V3 tip,
codon 36 (the second codon of the tetramer) being the only codon
located within the tip (Fig. 4).
Discussion
The HIV-1 subtype B strains continue to be the dominant viruses in
the Brazilian epidemic (Sa Filho et al., 2005). However, some variants
harbor the GWGR tetramer, which is quite antigenically distinct, at the
tip of the V3 loop (Casseb et al., 1998; Potts et al., 1993). These variants
account for approximately half of all subtype B-related infections in
Brazil (Casseb et al., 2002; Morgado et al., 1994; Potts et al., 1993;
Santoro-Lopes et al., 2000). It has been speculated that these variants
are associated with slower disease progression (Casseb et al., 2002;
Morgado et al., 1994; Potts et al., 1993; Santoro-Lopes et al., 2000).
Notably, we conﬁrmed that the GWGR variants were present at a very
early stage of the Brazilian epidemic, as seen in the 1983 samples.
Together with other facts, the ﬁnding of GWGR sequences at this early
stage suggests a founder effect, rather than a constant evolution from
GPG to GWG in these human hosts. It can be speculated that P-to-W
substitution is a rare event, since it requires a three-nucleotide
substitution (tgg to ccc) at this position, and W is not found in other
clades that circulate in Brazil (clades F and C). Other unique aspects of
this 1983 cohort of MSM are the extremely high incidence and
prevalence of HIV infection. The considerably lesser mean pairwise
distance and limited non-synonymous substitution in this group also
suggests that the epidemic spread rapidly within this group at a very
early stage of the Brazilian HIV epidemic.
In the present study, the GWG variant was shown not to be
genetically unique among the subtype B strains investigated. Max-
imum likelihood trees using full-length and gp120 env fragments
from samples containing different V3 tip motifs obtained at distinct
time points in the Brazilian epidemic showed that subtype B strains
are phylogenetically undistinguishable (Fig. 1 and 2). In both trees,
Brazilian env sequences were evenly dispersed regardless of the
sampling time or V3 tip signature. The V3 motif at the tip of the loop
was excluded from the C2-V3-C3 sequences prior to the analysis in
order to avoid the impact that this signature might have on the
analysis of this short (216-bp) sequence fragment. The absence of a
GWGR cluster within the Brazilian C2-V3-C3 sequences clearly
indicated there were no other nucleotide signatures within this
fragment, in contrast to the idea that these sequences are segregated
from other Brazilian samples. Since the C2-V3-C3 sequences are only
216 bp in length, another tree using a longer (746-bp) gp120 env
fragment was constructed in order to conﬁrm the ﬁndings of the ﬁrst
tree. Within this second tree, which included the V3 motifs, variants
harboring GWGR did not cluster. Neither tree produced results that
would support the concept that GWGR variants are part of a well-
deﬁned clade of subtype B variants evolving in the Brazilian epidemic.
Nor did we ﬁnd any evidence that env sequences could be
differentiated according to the time point (in the course of theepidemic) at which samples were obtained. Although we analyzed
samples collected between 1983 and 1999 (spanning 16 years of the
epidemic), no major differences in branch length or phylogenetic
segregationwere observed. It should be noted that both analyses were
based on env fragments, with limited sequence information due to the
short length of the fragments analyzed. Therefore, we performed
additional analyses of ﬁve full-length genome sequences of GW
viruses isolated in Brazil. Similarly, we found that GW viruses did not
form a unique cluster and were not distinguishable from other full-
length genome sequences of clade B viruses previously isolated in
Brazil. The full-length tree also indicated that, with the exception of
one sample (BR.89.BZ167), all of the sequences of GW viruses isolated
in Brazil might have a common ancestor, regardless of the signature in
the tetramer of V3 loop region of env gene.
Brazilian env sequences were further investigated by measuring
mean pairwise distances and calculating dN/dS ratios. In that analysis,
sequences were grouped into different data sets by V3 tip motif
(GPGR, GWGR and others) and by sampling date (1983, 1994, 1995 and
1999). Sequences were also grouped by patient clinical status at the
moment samples were collected (symptomatic or asymptomatic).
Mean pairwise distances related to V3 tip motif ranged from 0.14 (in
the BR-GWGR data set) to 0.24 (in the data set consisting of sequences
presenting neither GWGR nor GPGR motifs). The greater mean
distance observed in the latter data set might be due to the presence
of distinctive V3 signatures (APGR, GRGR, GGGR, etc), which would
have also caused an increase in the standard error, or to a longer
period of evolution of these strains. The mean pairwise distance in the
BR-GPGR data set was 0.16, compared with 0.13 in the BR-GWGR data
set. Mean pairwise distances in the data sets grouped by sampling
date did not vary greatly, ranging from 0.13 in the BR-83 data set to
0.20 in the BR-95 data set. These results demonstrate that, although
the variation is not great, there is a trend toward lower genetic
diversity early in the epidemic and in the GWGR group of sequences.
In addition, the genetic distances were greater among symptomatic
patients than among asymptomatic patients. Mean pairwise distance
obtained for the symptomatic patient data set was 0.16, whereas it
was 0.19 and 0.21, respectively, in the Sympt-SP (b200 cells/μL) and
Sympt-AP (≥200 cells/μL) data subsets.
Pairwise dN/dS (ω) estimates indicated that all the abovementioned
data sets were under selective regimes close to neutrality, since the t-
test indicated ω values not different from 1 (Table 2). Pairwise
distances and dN/dS estimates suggested that Brazilian subtype B
sequences do not have any V3 variants under speciﬁc selective
regimes, nor do they present distinct evolutionary rates. Although
based on data related to short sequence fragments, our study did not
identify any phylogenetic or genetic features distinguishing GWGR
variants from other subtype B variants circulating in Brazil. Therefore,
observations made in other studies implying that GWGR variants
harbor particular biological features that result in slower disease
progression might not be unrelated to the genetic signatures and
differential evolutionary rates of the env gene. Interestingly, our
pairwise analysis results indicate that the ω value was slightly higher
(1.23) in the patients with CD4 counts ≥200 cells/μL. Although not
statistically different from 1 according to the t-test, this slightly higher
ω value reveals a tendency toward dN elevation (Table 2). Since these
sequences contained distinct V3 variants (Fig. 1), the higher ω values
might reﬂect patient immune status rather than the presence of a
speciﬁc V3 signature. These results, together with the ﬁnding that
branch lengths were longer in sequences obtained from symptomatic
patientswith CD4 counts ≥200 cells/μL than in other sequences within
the same phylogenetic pairs (Fig. 1), led us to perform a more detailed
analysis of the selective regimes in these sequences.
We used a codon-based maximum likelihood method to compare
the selective pressures among symptomatic patients separated by CD4
counts into the subsets of those with CD4 counts b200 cells/μL and
those with CD4 counts ≥200 cells/μL. The results of this analysis
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Table 2
Pairwise analysis of evolutionary distances and dN/dS ratios in the HIV-1 C2-C3
envelope fragment
Data set
(n)a
Mean distance
(s.e)b
dN (SE) dS (SE) dN/dS
(t-test)c
All-BR
(81)
0.17891 (0.01776) 0.17302 (0.02503) 0.19995 (0.04190) 0.8652
(t=0.549)
BR-GWGR
(28)
0.13642 (0.01371) 0.13181 (0.01792) 0.15169 (0.02981) 0.8689
(t=1.031)
BR-GPGR
(45)
0.16549 (0.01455) 0.16036 (0.02567) 0.18354 (0.0378) 0.8737
(t=0.527)
Other-V3
(8)
0.24146 (0.02040) 0.23184 (0.03326) 0.27470 (0.05118) 0.8439
(t=0.570)
BR-99
(15)
0.19117 (0.01629) 0.17690 (0.02191) 0.24155 (0.04012) 0.7323
(t=1.175)
BR-95
(26)
0.20362 (0.01885) 0.19685 (0.03004) 0.23244 (0.04467) 0.8468
(t=0.595)
BR-94
(25)
0.18415 (0.02536) 0.18415 (0.02536) 0.20388 (0.04291) 0.9032
(t=0.383)
BR-83
(15)
0.132489 (0.01496) 0.12984 (0.01839) 0.14155 (0.03887) 0.9173
(t=0.355)
Asympt.
(55)
0.16460 (0.01502) 0.17361 (0.0228) 0.20511 (0.03836) 0.8464
(t=0.657)
Sympt-SP
(13)
0.19570 (0.01980) 0.18698 (0.02750) 0.22555 (0.04458) 0.8289
(t=0.678)
Sympt-AP
(13)
0.21558 (0.02018) 0.22794 (0.03450) 0.18403 (0.03173) 1.2386
(t=0.820)
a Asympt, asymptomatic patients; Sympt-SP, symptomatic patients with CD4
counts b200 cells/μL; Sympt-AP, asymptomatic patients with CD4 counts ≥200
cells/μL; Other, other forms of V3 loop tetramer (GGGR, GFGR, etc.)
b Mean pairwise distance determined in a 216-bp envelope fragment, according to
Kimura's 2-parameter model implemented using the MEGA3 software package, version
3.1.
c dN/dS signiﬁcantly different from 1 for the 1% signiﬁcance level with a t-test, where
t=(dS−dN)/√[(SE(dS2)+SE(dN2)] with inﬁnite degrees of freedom.
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terms of the selective regimes. Speciﬁcally, for those with CD4
counts b200 cells/μL, the best-ﬁt model (model 1) indicated that
56.5% of codons were conserved (ω=0) and 43.5% were under
neutral regime (ω=1). However, for the patients with CD4 counts
≥200 cells/μL, the best-ﬁt model (model 3) indicated that 37% of
codons under positive selection (ω=1.6). In addition, the latter
model identiﬁed eight codons with a high (99%) a posteriori
probability of being under positive selection (Fig. 3). Although
those codons were located near the V3 loop, only the codon at the
second position of this tetramer (codon 36; Fig. 3) was positively
selected. It is noteworthy that, within the data subset related to
patients with CD4 counts ≥200 cells/μL, various V3 motifs were
identiﬁed. It is quite reasonable to suggest that positive selection is
the main driving force of V3 loop tetramer diversiﬁcation. In
summary, the relatively greater genetic diversity in the group of
symptomatic patients with higher CD4 counts, taken together with
the higher dN/dS ratios, suggests that there is greater selective
pressure exerted by a more preserved immune system even in the
presence of AIDS-deﬁning conditions.
Our ﬁndings indicate that Brazilian subtype B strains presenting
GWGR tetramers at the tip of the V3 loop were neither phylogen-
etically nor genetically distinct from those presenting GPGR tetra-
mers. Codon-based maximum likelihood analyses identiﬁed codons
under positive selection in the vicinity of and within the V3 tetramer
in patients with CD4 counts ≥200 cells/μL, thereby showing that,
even during the symptomatic period, the immune system readily
recognizes and intensively responds to viral proteins. Finally, the factFig. 3.Maximum a posteriori tree constructed from 56 full-length genomes of HIV-1 subtype
depicted as a green branch.Within this cluster, the isolates presenting GWGR at the tip of the
isolates from Argentina and Uruguay appear in cyan. Values at the nodes represent Bayesian
colour in this ﬁgure legend, the reader is referred to the web version of this article.)that the frequency of GWGR variants remains high in Brazil is likely
due to complex combinations of stochastic and deterministic forces
such as founder effects, host cell factors and immune pressure. Since
the prevalence of GWGR strains is the same as that of GPGR strains
among individuals with higher CD4 counts, the transmission ﬁtness
of this variant is probably high. The great majority of HIV
transmissions will occur close to the primary/recent infection
(Brenner et al., 2007), and infecting individuals will therefore
continue to harbor signiﬁcant loads of the GWGR strain during this
period. As disease progresses, the probability for tryptophan (tgg)
disappearance increases, being replaced to closer amino acids such as
G (ggg), A (gcg), V (gtg), E (gag), R (agg) and L (ttg), which are
frequently found in Brazilian individuals with clade B strains and low
CD4+ T cell counts. Using serological methods, we found that
individuals harboring the abovementioned GWGR-related sequences
will react as GWGR-infected individuals in the peptide-binding assay,
suggesting that the GWGR sequence has been present in these
individuals in the past. Other evidence, especially the fact that, in
individuals with lower CD4+ T cell counts, the prevalence of GWGR
sequences was found to decrease as the prevalence of sequences
harboring other motifs increases (Table 1), corroborates this hypoth-
esis. This, together with our ﬁnding that the mean pairwise distance
is less in the GWGR sequences than in the GRGR sequences, suggests
that genetic evolution is relatively more rapid in the GWGR
sequences. Other interesting insights into the evolution from
GWGR to other motifs are found in a study describing a patient
failing antiretroviral therapy and harboring HIV strains with GGGR
motif at the tip of the V3 loop, X4 related strains, and antiretroviral
resistant strains (Silva et al., 2006). That patient presented the de
novo appearance of GWGR, R5, and wild type viruses after
antiretroviral interruption. This reversion to ancient viruses driven
by the interruption of antiretroviral therapy, as seen in other study
(Wang et al., 2007), further suggests that sequences presenting GGGR
at the tip of the V3 loop evolve from GWGR sequences.
We recognize the fact that the small number of sequences analyzed
here and the lack of a prospective cohort of infected individuals
precludes the drawing of deﬁnite conclusions. Nevertheless, we
believe that speculative studies of disease progression in GPWR-
infected individuals in comparison with GWGR-infected individuals
should be performed using the genetic characterization of the viruses
and should take into account the possibility that tryptophan
substitution occurs during the course of the infection.
Material and methods
Population studied
In a study of sexual transmission of hepatitis B conducted in 1983
at the Federal University of São Paulo School of Medicine, in São Paulo,
Brazil, samples of sera were obtained from 66 menwho have sex with
men (MSM). These samples were aliquoted and stored undisturbed
until gathered for retrospective analysis in the current study. Of the 66
samples analyzed, 24 (36%) were found to be anti-HIV-positive by
enzyme immunoassay (EIA) and Western blot. All HIV-seropositive
patients were asymptomatic for HIV infection in 1983. Follow-up
samples collected in 1986 from 4 of those same individuals were also
analyzed as controls for ampliﬁcation carryover. Fifteen of the 66
samples yielded a quantity of HIV RNA sufﬁcient for sequencing.
Follow-up samples collected in 1985 from 3 other individuals in the
same group were also analyzed and served as quality controls for theB. The cluster formed by HIV-1 subtype B isolates from Brazil, Argentina and Uruguay is
V3 loop are represented by blue branches. Isolates from Brazil appear in yellow, whereas
a posteriori statistical support for the tree clades. (For interpretation of the references to
Table 3
Maximum likelihood analysis of dN and dS in the 216 bp HIV-1 C2–C3 envelope fragment
Codon Model -lnL LRT Positive selected sites with p≥ =0.99 Parameters estimated
Dataset: Sympt-SP (n=13 l=216)
M0 1329.395841 M0vsM2=90.571,p=0.0000 Not allowed k=3.02018 ω=0.4274
M0vsM3=92.115,p=0.0000
M1⁎ 1287.986512 M1vsM2=7.752,p=0.0207 Not allowed ω0=0.00000 ω1=1.00000
M1vsM3=9.297,p=0.0541 p0=0.56490 p1=0.43510
k=3.29265
M2 1284.110418 M2vsM3=1.544,p=0.4619 59 p0=0.53287 p1=0.44852 p2=0.01862
ω0=0.12103 ω1=1.00000 ω2=5.39443
k=3.31029
M3 1283.338243 59 p0=0.45278 p1=0.44371 p2=0.10352
ω0=0.08028ω1=0.65745ω2=1.94196
k=3.32591
M7 1287.267699 M7vsM8=7.399,p=0.0247 Not allowed p=0.43307q=0.59640
ω7=0.4206
k=3.18457
M8 1283.568421 59 p0=0.98051p=0.45320 q=0.61815
(p1=0.01949) ω=4.34892
k=3.24260
Dataset: Sympt-AP (n=13 l=216)
M0 1475.793066 M0vsM2=124.824,p=0.0000 Not allowed k=2.35419 ω=0.5215
M0vsM3=135.939,p=0.0000
M1 1416.058805 M1vsM2=5.355,p=0.0687 Not allowed ω0=0.00000 ω1=1.00000
M1vsM3=16.471,p=0.0024 p0=0.48603 p1=0.51397
k=2.64647
M2 1413.381123 M2vsM3=11.115,p=0.0039 None p0=0.45830 p1=0.34361 p2=0.19810
ω0=0.09932 ω1=1.00000 ω2=2.06348
k=2.84594
M3⁎ 1407.823484 33, 36, 45, 59, 62, 64, 65, 67 p0=0.23570 p1=0.39592 p2=0.36839
ω0=0.00000 ω1=0.35099 ω2=1.61380
k=2.86383
M7 1413.951567 M7vsM8=8.837,p=0.0120 Not allowed p=0.26601 q=0.25572
ω7=0.5099
k=2.64588
M8 1409.533019 67 p0=0.68773 p=0.41114 q=0.95405
(p1=0.31227) ω=1.69989
k=2.85701
⁎ Best-ﬁt model according to the LRT. p=proportion of codons under a deﬁned category of ω (dN/dS) value. Sympt-SP=symptomatic patients with CD4 levels below 200 cells/μL.
Sympt-AP=symptomatic patients with CD4 levels above 200 cells/μL.
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samples. The second set consisted of 25 serum samples obtained in
1994 from asymptomatic blood donors. The third set was composed of
serum samples obtained in 1995 from 26 patients with signs or
symptoms of AIDS. Among those 26 patients, CD4+ T cell counts were
b200 cells/μL in 13 and 200 to 300 cells/μL in the remaining 13. The
fourth set consisted of DNA samples collected in 1999 from 15
asymptomatic, untreated HIV-1-positive patients. An additional 5
samples collected in 2004 from recently infected individuals present-
ing the GWGR motif at the tip of the V3 loop were used for the full-
length genome analysis. All samples presented here are from
individuals not receiving antiretroviral therapy and therefore repre-
sent the natural evolution of HIV within the hosts.
Determining HIV-1 incidence
Using the serologic testing algorithm for recent HIV seroconver-
sion (STARHS) (Janssen et al., 1998), we determined the incidence rate
in the 1983 sample set. As this is the oldest set of samples of HIV-1
infected individuals in Brazil, we understood it would be interesting
to evaluate the HIV incidence at that time in a country considered to
be the epicenter of HIV epidemics in South America. The STARHS
consists of a serologic testing algorithm to distinguish persons with
early HIV-1 infection from other HIV-infected persons. The algorithm
is based on the facts that (i) antibodies to HIV increase progressively
over several months in recently infected individuals, and (ii) this
period can be lengthened by modifying an EIA to make it less
sensitive. For the more sensitive assay, we used a whole viral lysate-
based EIA for HIV-1 (3A11, Abbot Laboratories, Chicago, IL, USA)according to the manufacturer instructions. For the less sensitive
EIA, the following elements of the 3A11 test were modiﬁed as
previously described (Janssen et al., 1998): sample dilution, sample
incubation time, and conjugate incubation time. To further reduce
the sensitivity in the less sensitive version of the 3A11, the cutoff for
optical density (OD) was also increased to 0.7. This strategy was pre-
validated by testing 690 serial samples from 104 seroconverting
individuals using the sensitive EIA (3A11) and the less sensitive
version of the same assay (3A11-DT). It was determined that the
mean interval between the point at which the 3A11 (reactive) assay
can identify an individual with early HIV infection through
evaluation of a blood specimen and that at which the 3A11-DT
(nonreactive) assay can thus identify such an individual is 129 days
(95% conﬁdence interval=109–149 days). Annual incidence was
estimated as follows:
I ¼ ndt=Nð Þ  365=wð Þ
where I is the incidence (seroconversions per person–year), ndt is
the number of persons with 3A11-positive/3A11-DT-negative
results, N is the number of susceptible HIV-negative persons, and
w is the estimated mean time between seroconversion determined
using the 3A11 assay and that determined using the 3A11-DT assay
(129 days).
We analyzed, in a blinded fashion, a panel of 39 samples that
included the 24 available samples from the 25 collected from HIV-1-
infected MSM in 1983, 6 duplicate samples from those 24, 4 follow-up
samples collected from those same individuals in 1986, and 5 HIV-
negative control samples drawn in 1983.
Fig. 4.HIV-1 C2–C3 dN/dS codon values in sequences obtained from symptomatic patients with CD4 counts ≥200 cells/μL. Codons with the highest a posteriori probabilities of positive
selection are indicated by red arrows. The V3 tip is circled in red. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this
article.)
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As shown in Table 4, synthetic biotinylated peptides based on the
V3 region of HIV gp120 were used. Microplates (Immulon II round
bottom; Dynatech Laboratories) were coated with avidin DX diluted in
PBS, pH 7.4, at 10 μg/mL overnight at 4 °C. The peptides were
biotinylated and were diluted 1 μg/mL in PBS, pH 7.4, 0.1 mL/well and
incubated overnight at 4 °C. The plates were washed ﬁve times with
PBS/0.05% Tween-20 and blocked with PBS plus 5% dry milk without
Tween for 1 h at 37 °C, after which they were washed ﬁve additional
times with PBS/Tween. Serum dilutions in PBS plus 5% dry milk plus
0.05% Tween-20 (Blotto) were then added (0.1 mL/well, starting at
1:50), and this was followed by a 1-h incubation at 37 °C. All runs
included a human HIV-1-positive plasma pool as control. Each plate
was run in duplicate: one replicate plate was washed ﬁve times with
PBS-Tween 20; the other was washed ﬁve times with 8 M urea in PBS.
Peroxidase labeled anti-human IgG (diluted 1:10.000 in Blotto) was
added (0.1 mL/well), and the plates were incubated for 1 h at 37 °C,
after which they were washed 5 times with PBS/Tween. The plates
were then incubated with 0.15 mL/well of TMB substrate for 30 min at
room temperature. The reactionwas stopped with 0.50 mL/well of 4 N
H2SO4 solution. The plates were read at 450 nm, and the endpointTable 4
Biotinylated peptides used in the peptide-binding assay
Sequencea Peptideb Homology (%)
BR1 N T R K S I H I – – G W G R A F Y 100
BR2 . . . . . . . M – – . . . . . . . 93
SF2 . . . . . . Y . – – . P . . . . H 80
MN . K . . R . . . – – . P . . . . . 80
3B . . . . R . R . Q R . P . . . . . 60
a BR1 and BR2 are the consensus sequences for the Brazilian strain containing the
GWGR motif at the tip of the V3 loop. SF2, MN, and 3B are American strains, and all
strains used are from HIV-1 clade B.
b Points indicate amino acid identities, whereas dashes indicate gaps.titer was calculated as the dilution producing a mean absorbance of
0.5.
The scheme for classifying themotifs asWor P was as follows. Four
ratios of the arithmetic titer ratios were calculated: BR1/SF2; BR1/MN;
BR2/SF2, and BR2/MN′. The sum of all four ratios was computed. Sera
presenting a sum ratio b8 were classiﬁed as P, whereas those
presenting a sum ratio between 8 and 16 were classiﬁed as
indeterminate, and those presenting a sum ratio b16 were classiﬁed
as W.
Viral RNA isolation and reverse transcription PCR
To extract RNA, the Boom et al. method was applied, as previously
described (Boom et al., 1990), to ≤200 μL of serum. The RNA was then
converted into cDNA by reverse transcription (RT)-PCR (Gibson, Mori,
and Clewley, 1993). In brief, RNA was recovered by binding to silica in
the presence of guanidinium thiocyanate and subsequent elution in
40 μL of RNase-free water. Twenty microliters of the eluted RNA were
combined with 10 pmol of an HIV-speciﬁc antisense primer (Wolfs
et al., 1990), denatured for 10 min at 65 °C and immediately placed on
ice. The mixture was incubated at 42 °C for 45 to 60 min in 40 μL of a
solution containing 50 mM Tris–HCl, 40 mM KCl, 5 mM MgCl2, 0.5%
Tween 20, 10 mM dithiothreitol, 20 U of RNasin (catalog no. N251a;
Promega), 50 U of Expand Reverse Transcriptase (catalog no. 1785834;
Boehringer Mannheim) and each deoxynucleoside triphosphate at a
concentration of 1 mM. The reaction was stopped by putting the
mixture on ice, after which the cDNA for the C2–V3–C3 region
(designated the V3 region for simplicity) of the env gene was
immediately ampliﬁed using nested PCR. The nested PCR was
performed in 10 mM Tris (pH 8.3), 50 mM KCl, 3 mM MgCl2, 200 μM
of each deoxynucleoside triphosphate, 0.2 μM of each primer and
2.5 U Taq polymerase (Perkin Elmer) per 100 μL of reaction mix. In the
second round of nested PCR, 5 μL of the ﬁrst-round PCR product was
used. Nested ampliﬁcation of the cDNA for the V3 region was
performed using primers described elsewhere (Wolfs et al., 1990).
192 R.S. Diaz et al. / Virology 381 (2008) 184–193Thermal cycling conditions for V3 were 35 cycles of 95 °C for 1 min,
55 °C for 1 min, and 72 °C for 2 min, with a ﬁnal extension at 72 °C for
10min. Full-length genomes of the samples collected in 2004 from the
5 recently infected individuals were ampliﬁed and sequenced as
previously described (Santos et al., 2006).
Sequencing
Puriﬁed PCR products were sequenced bidirectionally using the
ABI PRISM BigDye Terminator Cycle Sequencing Ready Reaction Kit
with AmpliTaq DNA polymerase (Applied Biosystems). The reaction
products were sequenced and analyzed using an automated sequen-
cer (ABI 3100; Applied Biosystems). Sequences were edited using the
Sequencher 4.0 software (GeneCodes). The GenBank accession
numbers of sequences are FJ195020 to FJ195091.
Alignment and phylogenetic inference
The sequences were manually aligned using the Se-Al program
(version 2.0; Department of Zoology, Oxford University [http://evolve.
zoo.ox.ac.uk/software/]). Sequences with insertions/deletions and
stop codons were excluded from the alignments. Sets of HIV-1
subtype reference sequences obtained from the GenBank were
included in the alignments. Phylogenetic inferences were made
using the general time-reversible nucleotide substitution model
(Rodriguez et al., 1990). Maximum likelihood trees were ﬁrst
determined by the neighbor-joining method, after which they were
swapped using the nearest-neighbor interchange method. phyloge-
netic inferences regarding the maximum likelihood trees were made
using the PAUP program (Swofford, 2002). The Bayesian tree of full-
length genomes was also obtained through the use of the MrBayes
program, version 3.1.2 (Ronquist and Huelsenbeck, 2003), with the
GTR+ gamma correction model. We made two independent runs of
7×106 generations each (the initial 10% of the generations were
discarded as burn-in) and sampled every 100th generation.
Analysis of selection pressures
We used pairwise and maximum likelihood codon-speciﬁc
methods to estimate selection pressures. Initially, we compiled data
sets as previously described and determined the mean dN/dS using the
pairwise method of Nei and Gojobori as implemented in the MEGA3
software package, version 3.1 (Kumar, Tamura, and Nei, 2004). For the
codon-speciﬁc analyses, we used the CODEML program of the PAML
package, version 3.14 (Yang, 1998). This approach compares the ﬁt to
the data of various models of codon evolution, which differ in the
distribution of dN/dS (ω) among sites, and takes into account the
phylogenetic relationships among the sequences:
➢ Model 0 (one-ratio) assumes a single ω for all sites in the
alignment and hence is the simplest model speciﬁed.
➢ Model 1 (neutral) allows different proportions of conserved sites
(ω=0) and neutral sites (ω=1), both estimated from the data.
➢ Model 2 (selection) adds an additional class of sites, and its ω ratio
(which can be N1) is estimated from the data.
➢ Model 3 (discrete) also allows positive selection by incorporating
three categories of codon sites, and its ω value at each site is
estimated from the data.
➢ Model 7 speciﬁes ten categories of ω, none of which may be b1,
and the model therefore allows only neutral evolution.
➢ Model 8 employs the ten model 7 categories and incorporates an
eleventh class of sites that can take on any value of ω, including
those supporting positive selection.
Nested models can be compared using a standard likelihood ratio
test. Signiﬁcant evidence for positive selection is provided if model 2
or (as is more common) model 3 signiﬁcantly rejects the nullhypotheses of model 0 and model 1, and if model 8 signiﬁcantly
rejects that of model 7, as well as if the favored models contain a class
of codons in which ω is N1.
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